While many cases are treatable, a subset can become highly aggressive, spreading to distant organs and resisting conventional therapies
The study is being conducted through its Japan-based pharmaceutical arm, Asahi Kasei Therapeutics Corp
Together, the companies aim to deliver an integrated toolkit for biomarker discovery and clinical research
The programme integrates simulation-based training, expert-led sessions, and case-based discussions
The newly formed team is led by Tomabu Adjobimey, an immunologist known for his work in host-pathogen interactions and immune modulation
OneSource is the contract development and manufacturing organization (CDMO) partner for this product
The programme has already drawn over 120 complex percutaneous coronary intervention (PCI) case submissions from across the country
Spread across 7,000 square feet, the Bengaluru facility is positioned as a purpose-built clinical prevention centre focused on identifying silent, life-threatening diseases in asymptomatic individuals
AI-enabled learning platform to enhance clinical quality, patient outcomes, and staff engagement across Eastern India network
In his new role, Curtis will lead the formulation and execution of the company’s global technical strategy
Subscribe To Our Newsletter & Stay Updated
